Our Podcasts

Advances in the Treatment of Chronic Myelogenous Leukemia

Improving Cancer Care Through Nursing Research and Patient Outcomes

Lung Cancer Screening and Prevention: Are We Reducing Lung Cancer Mortality?

Management of Tumor Lysis Syndrome

Managing Effects of Cancer Therapy: Lymphedema

NCCN 2nd Annual Congress: Hematologic Malignancies
Blood Products and Growth Factors in the Treatment of Thrombocytopenia

NCCN 2nd Annual Congress: Hematologic Malignancies
Cutaneous T-Cell Lymphoma

NCCN 2nd Annual Congress: Hematologic Malignancies
Initial and Subsequent Lines of Treatment in Multiple Myeloma

NCCN 2nd Annual Congress: Hematologic Malignancies
Managing Infections in Patients with Hematologic Malignancies

NCCN 2nd Annual Congress: Hematologic Malignancies
Multiple Myeloma: How to Treat Patients that Progress or Relapse

NCCN 2nd Annual Congress: Hematologic Malignancies
Myelodysplastic Syndromes: Implications of the 2008 WHO Reclassification

NCCN 2nd Annual Congress: Hematologic Malignancies
Myelodysplastic Syndromes: Treatment by Risk Groups

NCCN 2nd Annual Congress: Hematologic Malignancies
Myelodysplastic Syndromes: Who Would Benefit From Immunosuppressive Therapy?

NCCN 2nd Annual Congress: Hematologic Malignancies
Non-Hodgkin’s Lymphoma: Low-Grade Lymphomas

NCCN 2nd Annual Congress: Hematologic Malignancies
Non-Hodgkin’s Lymphoma: Mantle Cell Lymphoma

NCCN 2nd Annual Congress: Hematologic Malignancies
Skeletal Complications

NCCN 2nd Annual Congress: Hematologic Malignancies
Transfusion Support and Iron Overload in Myelodysplastic Syndromes

NCCN 2nd Annual Congress: Hematologic Malignancies
Treatment of Acute Myeloid Leukemia

NCCN 2nd Annual Congress: Hematologic Malignancies
Treatment of Systemic Light Chain Amyloidosis

NCCN 2nd Annual Congress: Hematologic Malignancies
Tumor Lysis Syndrome

NCCN 2nd Annual Congress: Hematologic Malignancies
Update on Primary Therapy, Second-Line Therapy, and New Agents for Chronic Myelogenous Leukemia

NCCN Breast Cancer Guidelines Update

NCCN Clinical Practice Guidelines in Oncology Symposium: Breast Cancer - Adjuvant Therapy: Chemotherapy, Hormonal Therapy

NCCN Clinical Practice Guidelines in Oncology Symposium: Breast Cancer - Primary Treatment:
Update on Sentinel Node Biopsy and Axillary Dissection, Surgery, and Radiation

NCCN Clinical Practice Guidelines in Oncology Symposium: Breast Cancer - Prognostic Factors

NCCN Clinical Practice Guidelines in Oncology Symposium: Breast Cancer - Treatment for Advanced Breast Cancer: Chemotherapy, Biologic Therapy, Hormonal Therapy

NCCN Clinical Practice Guidelines in Oncology Symposium: Kidney Cancer –
Emerging Issues

NCCN Clinical Practice Guidelines in Oncology Symposium: Kidney Cancer –
Initial Evaluation of Renal Cell Carcinoma and Surgical Management of Resectable Disease

NCCN Clinical Practice Guidelines in Oncology Symposium: Kidney Cancer –
New Paradigms for the Management of Unresectable and Recurrent Renal Cell Carcinoma

NCCN Clinical Practice Guidelines in Oncology Symposium: Kidney Cancer –
The Role of Cytokine Therapy in Unresectable or Recurrent Renal Cell Carcinoma

NCCN Clinical Practice Guidelines in Oncology Symposium: Non-Small Cell Lung Cancer - Neoadjuvant Combined Modality Therapy for Potentially Resectable Stage III Non-Small Cell Lung Cancer

NCCN Clinical Practice Guidelines in Oncology Symposium: Non-Small Cell Lung Cancer -
Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer

NCCN Clinical Practice Guidelines in Oncology Symposium:
Colon, Rectal, & Anal Cancers – Adjuvant Therapy for Locoregional Colon Cancer

NCCN Clinical Practice Guidelines in Oncology Symposium:
Colon, Rectal, & Anal Cancers – Management of Anal Cancer

NCCN Clinical Practice Guidelines in Oncology Symposium:
Colon, Rectal, & Anal Cancers – Surgical Approaches to Rectal Cancer

NCCN Clinical Practice Guidelines in Oncology Symposium:
Colon, Rectal, & Anal Cancers – Therapy for Advanced Disease

NCCN Clinical Practice Guidelines in Oncology Symposium:
Non-Small Cell Lung Cancer - Management of Metastatic Non-Small Cell Lung Cancer

NCCN Clinical Practice Guidelines in Oncology Symposium:
Non-Small Cell Lung Cancer - Therapy for Stages I, IIA, IIB, and IIIA (T3, N1) Non-Small Cell Lung Cancer

NCCN Clinical Practice Guidelines in Oncology Symposium:
Non-Small Cell Lung Cancer - Workup, Prognostic Factors, and Markers

NCCN Clinical Practice Guidelines in Oncology Symposium:
Non-Small Cell Lung Cancer – Novel Agents for the Therapy of Lung Cancer

NCCN Non-Small Cell Lung Cancer Guidelines Update

NCCN Prevention and Treatment of Cancer-Related Infections Guidelines Update

NCCN Task Force Report: Gastrointestinal Stromal Tumors (GISTs)

Prophylactic Therapy: Identifying Patients at Risk for Fever and Neutropenia

Quality of Life Decisions and Treatment Options for Localized Prostate Cancer

Recognition and Management of Delirium in Cancer Patients

Roundtable: Cancer Care – Cost, Access, and Value

Roundtable: The Role of the Journalist in the War on Cancer